Efficacy and safety of letermovir for cytomegalovirus prophylaxis in thoracic organ transplantation: a systematic review and meta-analysis. (PubMed, BMC Infect Dis) - Dec 30, 2025 - "LTV prophylaxis demonstrates promising efficacy and safety in reducing breakthrough CMV infection, low-level viremia, and adverse events in TOT recipients. Its favorable safety profile, particularly in mitigating leukopenia, highlights its potential as an effective alternative to VGC."
Clinical • Journal • Retrospective data • Review • Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Leukopenia • Transplantation
|
|
Abdullah Yousef Aldalati; Ahmad Al-Dabagh; Ayham Mohammad Hussein; Badi Rawashdeh; Bara M Hammadeh; Bassel Alrabadi; Khald Aldalati; Moath Albliwi; Mohammad Abuassi
|